Kartik Sehgal

18PUBLICATIONS
104CO-AUTHORS
Radiation therapyMolecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Emergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 07, 2026
Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.

|May 02, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer.

|Apr 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

|Oct 09, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.

Glenn J Hanna, Nicole Scarfo, Kee-Young Shin

|Sep 26, 2025
Personalized Thyroidology: Molecular Rewiring of Thyroid Nodule Management.

Kartik Sehgal

|Dec 23, 2024
A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.

Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller

Pageof 3

Frequent Collaborators

5 joint publications

Glenn J Hanna

5 joint publications

Robert I Haddad

4 joint publications

Jonathan D Schoenfeld

4 joint publications

Kristine Wong